2don MSN
‘I rolled out a new AI skin cancer screening tool at my work – I never expected it to save my life’
When 46-year-old Lynsey Robertson helped launch a new AI skin cancer screening tool at the GP surgery where she worked, she ...
In September 2025, the Russian Federal Medical and Biological Agency announced that its mRNA-based vaccine Enteromix had ...
A JAMA study finds cancer diagnoses in Americans under 50 have doubled since 1992, but deaths remain flat—raising concern about overdiagnosis.
A research team has developed an approach to significantly reduce the risk of cancer recurrence and metastasis after surgery, ...
A Lexington woman battling breast cancer chose a different technique in the radiology process that implants a SmartClip the ...
A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...
Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...
A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer types ...
A major randomized controlled trial of AI for screening mammography will fill a significant evidence gap for a tech already ...
Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...
Pharmaceutical Technology on MSN
FDA approves Lilly’s Inluriyo to treat advanced breast cancer
Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...
Pharmaceutical Technology on MSN
Imunon’s Phase III-stage IL-12 gene therapy alters tumour microenvironment in ovarian cancer
Bucking the trend of IL-12 therapy programme failures, Imunon’s IMNN-001 was bolstered by positive translational data in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results